Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 28, 2011
Distinct roles of Rab11 and Arf6 in the regulation of Rab11-FIP3/arfophilin-1 localization in mitotic cellsSenye Takahashi, Tomomi Takei, Hiroshi Koga, et al.Cancers|February 25, 2023
Explainable AI for Estimating Pathogenicity of Genetic Variants Using Large-Scale Knowledge GraphsShuya Abe, Shinichiro Tago, Kazuaki Yokoyama, et al.Cell Structure and Function|March 28, 2008
Recruitment of Tom1L1/Srcasm to endosomes and the midbody by Tsg101Yuko Yanagida-Ishizaki, Tomomi Takei, Ray Ishizaki, et al.FEBS Letters|April 23, 2013
EFA6 activates Arf6 and participates in its targeting to the Flemming body during cytokinesisTomoko Ueda, Ayako Hanai, Tomomi Takei, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 3, 2025
[Successful management of cardiac arrest due to cytokine release syndrome following chimeric antigen receptor T-cell therapy for multiple myeloma]Yuki Oda, Kota Sato, Kodai Kunisada, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 7, 2017
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancyMasahiro Ikeda, Rina Oba, Yumiko Yoshiki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2025
[Therapy-related myeloid neoplasms with inv (16)(p13.1q22);CBFB::MYH11 during treatment for AL amyloidosis]Kodai Kunisada, Mizuki Ogura, Yuki Oda, et al.Leukemia & Lymphoma|May 1, 2015
Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantationTakaaki Konuma, Seiko Kato, Jun Ooi, et al.Cureus|December 25, 2023
Real-World Clinical Outcomes in Patients With Multiple Myeloma Administered With Elotuzumab-Based TreatmentTaku Kikuchi, Nobuhiro Tsukada, Yuki Oda, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2017
[IgE-κ type multiple myeloma achieving complete response with novel agents]Tomomi Takei, Tadao Ishida, Masahiro Ikeda, et al.Pageof 3